China Shineway Pharmaceutical Group (CSWYY) Stock Price, News & Analysis

Company Overview

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of chinese medicines in the People's Republic of China and Hong Kong. The company offers chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.

Key Stats

• Today's Range: C$19.25 to C$19.25
• 50-Day Range: C$18.22 to C$19.25
• 52-Week Range: C$18.53 to C$19.25
• Volume: 2 shs
• Average Volume: 200 shs
• Market Capitalization: N/A
• P/E Ratio: 1.13
• Dividend Yield: 22.78%
• Price Target: N/A
• Consensus Rating: N/A

China Shineway Pharmaceutical Group Stock Analysis - MarketRank™

China Shineway Pharmaceutical Group scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for China Shineway Pharmaceutical Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of China Shineway Pharmaceutical Group is 1.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.10.

Price to Earnings Ratio vs. Sector

The P/E ratio of China Shineway Pharmaceutical Group is 1.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.18.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

China Shineway Pharmaceutical Group has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

China Shineway Pharmaceutical Group pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

China Shineway Pharmaceutical Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of China Shineway Pharmaceutical Group is 25.79%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

China Shineway Pharmaceutical Group has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.6 / 5
• News Sentiment: -0.91

News Sentiment

China Shineway Pharmaceutical Group has a news sentiment score of -0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for China Shineway Pharmaceutical Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, China Shineway Pharmaceutical Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.01% of the stock of China Shineway Pharmaceutical Group is held by institutions.

CSWYY Stock Analysis - Frequently Asked Questions

How have CSWYY shares performed this year?

China Shineway Pharmaceutical Group's stock was trading at C$18.53 at the beginning of 2025. Since then, CSWYY shares have increased by 3.9% and is now trading at C$19.25.
View the best growth stocks for 2025 here.

How do I buy shares of China Shineway Pharmaceutical Group?

Shares of CSWYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 6/4 Dividend: 5/02/2025
• Record date for 6/4 Dividend: 5/05/2025
• Dividend Payable: 6/04/2025
• Today: 6/13/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CSWYY
• CIK: N/A
• Web: www.shineway.com
• Phone: 86 31 1880 30066
• Fax: N/A
• Employees: 3,533
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 1.13
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A